Introduction
============

The identification and treatment of individuals with latent *Mycobacterium tuberculosis* infection is an essential element of the World Health Organization's (WHO's) End TB Strategy.[@R1] Individuals with such infection, who are thought to make up between a third and a quarter of the world's population, act as reservoir hosts and may develop into active cases of tuberculosis when reactivation is triggered by any of several known risk factors.[@R2]^,^[@R3] Up to one third of the household contacts of humans with untreated tuberculosis of the respiratory tract become infected with *M. tuberculosis* and the risk of infection is relatively high if the active index case has severe disease, exposure to the case is prolonged and exposure to ultraviolet light and ventilation are poor.[@R3] Compared with older children, infants and very young children with latent infection are more likely to develop active tuberculosis, especially the severe and life-threatening forms of the disease.[@R3] Recommendations therefore suggest that all children younger than five years who are household contacts of cases of pulmonary tuberculosis should be screened for active tuberculosis and, if found free of the active disease and otherwise eligible, given preventive treatment.[@R4]^,^[@R5]

The percentage of eligible child contacts who begin preventive treatment (hereafter called treatment coverage) is considered to be among the top 10 priority indicators for measuring the progress of the End TB Strategy at global and national levels.[@R6] According to WHO, in 2016, an estimated 1.3 million children younger than five years were eligible for treatment for the prevention of tuberculosis.[@R7] Although treatment coverage appears to have almost doubled between 2015 and 2016, it was estimated to be just 13% in 2016.[@R7] Global figures on another indicator, the proportion of exposed children who are investigated to exclude active tuberculosis and, if eligible, start preventive therapy, are not yet available.

The screening and treatment of contacts younger than five years, as recommended by the WHO, probably occurs in most countries with a high burden of tuberculosis.[@R8] In 2016-- 2017, however, very few countries in WHO's Africa Region reported having any kind of scheme for the monitoring and evaluation of their interventions against latent tuberculosis infection.[@R9] In addition, very few such countries had any system for the routine reporting of four core indicators, i.e. the percentages of child contacts screened for active disease, eligibility for treatment for the prevention of tuberculosis, initiating such treatment and completing such treatment, that could give useful insights as to their interventions' efficiency.[@R9]

Burkina Faso is a resource-constrained country in West Africa that has a national tuberculosis programme and health-information system that appear similar to those of many other countries in sub-Saharan Africa. In 2015, Burkina Faso was one of the African countries that had no system for the monitoring and evaluation of latent tuberculosis infection and related interventions.[@R9] Although a national policy for the systematic screening and treatment of such infection among people living with human immunodeficiency virus (HIV) and children younger than five years was already in place, the country did not have an efficient relevant recording and reporting system and only noted the number of children who were started on treatment for the prevention of tuberculosis.[@R10] The programmatic management of latent tuberculosis infection in children younger than five years was implemented through a passive contact-tracing system that probably missed many children who were eligible for preventive treatment.[@R10]

In 2016, in response to the shortcomings in Burkina Faso's tuberculosis control initiatives, we modified two existing reporting forms and developed a monitoring and evaluation system for all of the country's activities relating to latent tuberculosis infection. We analysed the data produced within the system over a 12-month period, i.e. from 1 April 2016 to 31 March 2017, and used the data to evaluate screening coverage and proportion of children starting on preventive treatment. At the time of our analyses, the corresponding data on treatment completion rates were not yet available. In a second study, we implemented a pilot project in one area of Burkina Faso to compare the active and passive tracing of contacts younger than five years and then documented the observed impacts of active tracing on some key indicators of latent tuberculosis infection.

Methods
=======

Nationwide monitoring and evaluation
------------------------------------

### Recording and reporting system

In early 2016 Burkina Faso's national tuberculosis programme, in collaboration with WHO and the University of Brescia, Italy, developed a simple register to document and report the numbers of children younger than five years who were household contacts of contagious tuberculosis cases and who were screened and, where appropriate, started and sometimes completed treatment for latent tuberculosis infection. This entailed revision of the existing national paper-based register of latent tuberculosis infection so that the register could be used to record data on each child who was younger than five years and had been declared as a close or household contact of a case of pulmonary tuberculosis that had been bacteriologically confirmed. All such children were registered and information on their eligibility for treatment, treatment initiation and treatment completion was included routinely ([Fig. 1](#F1){ref-type="fig"}).
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In March 2016, copies of the revised registration form were printed and distributed to each of Burkina Faso's 88 centres for tuberculosis diagnosis and treatment. At the same time, as part of the programme for the prevention of childhood tuberculosis, a national workshop was organized for training at least one health-staff member from each centre on the management, recording and reporting of latent tuberculosis infection.

The new registration form came into effect on 1 April 2016 and, in this paper, we present the data from the first 12 months of the form's use. As part of their routine activities, staff from the national tuberculosis programme regularly supervised the form's use either during visits to the centres for tuberculosis diagnosis and treatment, or in telephone conversations with the centres' staff.

The target population was defined as children younger than five years old who shared households with individuals who had smear-positive pulmonary tuberculosis. The identification and screening of such children for active tuberculosis, as well as the provision of six months of preventive treatment with isoniazid to each child found eligible for such treatment, were conducted in accordance with the recommendations of the national tuberculosis programme.[@R10]

Routinely, contact tracing was based on passive detection of eligible children, who were identified from information provided by the index cases, usually a parent or other close relative, and evaluated if brought to a centre for tuberculosis diagnosis and treatment, voluntarily, when invited by a health-care provider. Such children were clinically evaluated to exclude cough of at least two weeks' duration, weight loss or failure to gain weight, fever, night sweats, fatigue and/or reduced playfulness. Wherever possible, if any of these symptoms were recorded, the child was checked for active tuberculosis via chest radiography and gastric lavage to collect samples that were checked by smear microscopy and/or rapid diagnostic testing (Xpert® MTB/RIF; Cepheid, Sunnyvale, United States of America). All child contacts without active disease were considered eligible for isoniazid preventive therapy.

### Indicators

In March 2016, the pre-existing quarterly tuberculosis reporting form was modified to include information on the numbers of child contacts younger than five years who were reported, screened for active disease, found eligible for preventive treatment and started on preventive treatment ([Fig. 2](#F2){ref-type="fig"}). The data subsequently collected on the revised version of this form allowed the measurement of three WHO-recommended indicators of latent tuberculosis infection: (i) the screening coverage, i.e. the percentage of children reported as close or household contacts of bacteriologically confirmed cases of pulmonary tuberculosis who were checked for active disease; (ii) the treatment initiation proportion, i.e. the percentage of children found negative for active disease and considered eligible for preventive treatment who had actually initiated such treatment; and (iii) the proportion of children that completed preventive treatment.[@R7]
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Regional pilot study
--------------------

In a pilot study in the Hauts-Bassins region of Burkina Faso, we investigated how the replacement of the routine passive system of contact tracing with active household-based tracing by community health workers (CHWs) would affect the numbers of children deemed eligible for preventive treatment. Hauts-Bassins was purposefully selected as the study area for its convenience. In 2016, it was the region of Burkina Faso with the second highest number of contagious tuberculosis cases, after the Central region (A Combary, National Tuberculosis Programme of Burkina Faso, unpublished data, 2016). The estimated population of Hauts-Bassins in 2016 was 2 025 513 or about 10.6% of the total population of Burkina Faso.[@R11] The region includes both rural and urban districts and probably holds about 10% of the country's CHWs, who collaborate actively with local civil society organizations.

We compared data collected on tuberculosis during August and September of 2016, when active tracing of contacts by CHWs was implemented, with the corresponding data collected, in the same area, in June and July of 2016, when all contact tracing relied on the national system of passive detection. For the active tracing, CHWs were trained to visit the households of all bacteriologically confirmed cases of pulmonary tuberculosis, identify all children within the household who were younger than five years and educate the parents or caregivers of such children on the importance of screening child contacts for tuberculosis. Eventually, a tuberculosis nurse visited the household of each known confirmed case, checked all exposed children for the signs or symptoms of tuberculosis, referred all suspected paediatric cases of active tuberculosis to the nearest centre for diagnosis and treatment and started to give preventive treatment, directly within the household, to all eligible children. Our outcomes of interest were screening coverages, proportion of children starting on treatment and the numbers of contacts younger than five years identified per confirmed index case, known as the contact:index ratios.

We used the contact:index ratio estimated during the pilot study's active contact tracing to assess the effect that the national reliance on passive contact tracing had on the cascade of care for latent tuberculosis infection, and the corresponding WHO-recommended indicators.

Data analysis
-------------

Descriptive statistics were used to summarize observations made, during our main study period and with the revised latent tuberculosis infection register and quarterly tuberculosis reporting form, in each of Burkina Faso's 13 regions and nationwide. Since the pilot study was not intended to be a detailed statistical comparison, the analysis of the effect of active contact tracing on common indicators of latent tuberculosis infection was also descriptive.

Results
=======

Monitoring and evaluation system
--------------------------------

During the study period, the revised registration form was rapidly adopted in every centre for tuberculosis diagnosis and treatment and all scheduled revised quarterly reporting forms were completed by each such centre. Over the same period, 3717 cases of pulmonary tuberculosis were bacteriologically confirmed in Burkina Faso and 1166 contacts younger than five years were reported. The corresponding contact:index ratio was therefore 0.31 nationwide. However, the regional values for this ratio varied from 0.04 in the Sahel region to 0.46 in the Boucle de Mouhoun region.

Of the 1166 contacts younger than five years that were reported during the study period, 956 (82.0%) were checked for active tuberculosis. Regionally, screening coverage varied from 57.1% (164/287) in Hauts-Bassins to 100% (15/15) in the Sahel region.

Of the 956 children who were reportedly checked for active tuberculosis, 941 (98.4%) were declared eligible for isoniazid preventive therapy. The reasons why 15 children were declared ineligible were not reported. During the study period, 64 children younger than five years old were reported as new cases of active tuberculosis.

As 852 children were reported to have begun preventive treatment during our main study period, the overall proportion of children initiating treatment was 90.5% (852/941). Regionally, such proportions varied from 57.1% (20/35) in Cascases region to 100% (149/149) in the Nord region. According to information collected during routine supervisory visits, the main reason for not starting treatment was a temporary interruption in the isoniazid supply at health-facility level.

Pilot study
-----------

Although the type of contact tracing appears to have had little, if any, effect on the numbers of active index cases reported, i.e. 76 with passive tracing and 80 with active tracing, the use of active tracing appears to have markedly increased the reported number of child contacts younger than five years, i.e. from 48 with passive tracing to 146 with active tracing ([Fig. 3](#F3){ref-type="fig"}). The contact:index ratio for the active-tracing phase of the study was therefore much higher than that for the passive-tracing phase: 1.83 vs 0.63. The percentage of index cases found to have at least one exposed child younger than five years in their household also increased, from 23.7% (18/76) in the passive-tracing phase to 63.8% (51/80) in the active-tracing phase. However, the corresponding mean number of children younger than five years reported in a household with an index case remained more-or-less unchanged: 2.67 vs 2.86.
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Although screening coverage appeared markedly lower in the passive-tracing phase than in the active-tracing phase, 64.6% (31/48) vs 99.3% (145/146), the proportion of eligible children initiating treatment showed the opposite trend -- 100% (31/31) vs 78.6% (114/145). Again, supervisory visits revealed that most failures to start preventive treatment were the result of the unavailability of isoniazid.

If we assume that the 1.83 contact:index ratio recorded in the active-tracing phase of the pilot study was a true estimate of the contact:index ratio in the passive-tracing phase, and that all index cases were detected in the earlier phase, then there were 139 contacts younger than five years in Hauts-Bassins during the passive-tracing phase and not the 31 reportedly checked for active disease. The true screening coverage during the passive-tracing phase may therefore have been only about 22.3% (31/139), i.e. only about a quarter of the reported proportion.

Discussion
==========

By adapting tuberculosis recording and reporting tools to capture data on latent tuberculosis infection, the national tuberculosis programme was able to measure and report screening coverages and proportions of children initiating treatment for contacts younger than five years.

Our main study was limited to data collected routinely, using the revised national reporting system. The revised system proved to be feasible and allowed nationwide measurement of core global and national indicators, for activities related to latent tuberculosis infection, under routine programmatic conditions. No additional personnel were required and training sessions specifically focused on activities related to latent tuberculosis infection, including recording, reporting, monitoring and evaluation, were easily included in the general training programmes organized by the national tuberculosis programme.

National values for screening coverage (82.0%) and the proportion of treatment initiation (90.5%) recorded over our main study period indicated that, at least in Burkina Faso and provided that political commitment is maintained, the targets of the End TB Strategy are within reach. Although we do not report any treatment completion proportions, historical data from Burkina Faso indicate that about 81% of children who start isoniazid preventive treatment also complete it (A Combary, National Tuberculosis Programme of Burkina Faso, unpublished data, 2016). Among the children of Burkina Faso, therefore, failure to complete preventive treatment is probably not a major challenge in the cascade of preventive care. Hopefully, uptake of the latest recommendations from WHO on preventive treatment against latent tuberculosis infection in children, i.e. the replacement of six months of isoniazid with three months of rifampicin and isoniazid,[@R12] will increase the proportion of children completing treatment.

The global proportion of people initiating treatment estimated by WHO in 2016, 13%, is far from the target of 90% set to be reached by 2025.[@R6]^,^[@R7] The implementation and monitoring of preventive therapy in child contacts need to be scaled up at a rapidly increasing pace. This may be greatly facilitated by the development of better recording and reporting systems like the one described here. The denominators for the global indicators of latent tuberculosis infection are currently predominately represented by crude estimates that can only be improved by the collection of national data of good quality.[@R7] Here we provide a model for measuring contact screening coverage, an indicator that many countries might find challenging to capture.

Our pilot research project, on the effect on indicators relating to latent tuberculosis infection of active contact tracing within the households of index cases, revealed that many exposed children were probably being missed by passive contact tracing. Compared with routine passive tracing, the active tracing appears to have resulted in a threefold increase in the absolute number of children initiating preventive treatment. Passive contact tracing, which is currently adopted by most countries in sub-Saharan Africa, may leave as many as two thirds of eligible children without access to screening and treatment.

Unexpectedly, we recorded a lower proportion in treatment initiation in the active-tracing phase than during the passive-tracing phase. This is probably the result of the sudden increase in the number of children considered eligible for treatment, as the result of active tracing, without a simultaneous corresponding increase in the provision of isoniazid. Control programmes attempting to improve contact identification should expect and prepare for an increased demand for preventive treatment. In the centres for diagnosis and treatment that always had isoniazad available, every eligible child that was identified via active tracing started preventive therapy. The active-tracing model that we investigated appears to have been accepted well by both the general population and the health-care workers.

We were also surprised that, in our main study, only 15 out of the 956 children screened were considered ineligible for isoniazid preventive therapy. We expected more exclusions because of active tuberculosis in the screened contacts. However, paediatric tuberculosis can be hard to diagnose, particularly in the early phases of the disease.[@R4] New tools for the early detection of tuberculosis in children are clearly required. In this respect, the identification of clinically-suitable tuberculosis biomarkers and the description of transcriptional signatures of incipient disease hold promise, especially for young contacts.[@R13]^,^[@R14]

Problems in measuring the first step of the cascade of care for the prevention of tuberculosis, i.e. capturing data on children eligible for screening, can distort the whole cascade. Our data indicate that estimates of screening coverage based on routinely reported data and passive contact tracing may be much higher than the true coverage.

Both our main study and pilot study had limitations. Our feasibility analysis of the monitoring and evaluation system was incomplete as we did not collect data on costs and could not evaluate the system's cost--effectiveness analysis. The value of our estimate of the benefits of active contact tracing at household level is limited by the short period of implementation, potential seasonal bias in the data and the relatively small sample.

In conclusion, by revising an existing register and reporting form, we facilitated the routine collection of data on activities related to latent tuberculosis infection in a resource-poor country in sub-Saharan Africa. We anticipate that the recording and reporting tools that we developed could be incorporated into current health information systems. Our main study probably had an important side-benefit: the increased sensitization of health managers and health-care workers with regard to the prevention and care of childhood tuberculosis. Our pilot study indicated that many children who were eligible for preventive treatment are being missed as the result of the passive identification and recruitment of exposed children. Research is needed on the feasibility and value of the large-scale implementation of active tracing of contacts younger than five years, by CHWs making household visits and of the effective checking of children for active tuberculosis at peripheral health centres.
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